Clinical Performance Assessment of Two Silicone Hydrogel Daily Disposable Contact Lenses
1 other identifier
interventional
114
1 country
7
Brief Summary
The purpose of this study is to assess the overall clinical performance of a contact lens made with a modified manufacturing process.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2023
Shorter than P25 for not_applicable
7 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 3, 2023
CompletedFirst Posted
Study publicly available on registry
February 13, 2023
CompletedStudy Start
First participant enrolled
June 2, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 27, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 27, 2023
CompletedResults Posted
Study results publicly available
August 6, 2024
CompletedAugust 6, 2024
July 1, 2024
25 days
February 3, 2023
June 24, 2024
July 15, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Least Squares Mean Distance Visual Acuity (VA) With Study Lenses at Day 4
VA was assessed for each eye individually at a distance of 4 meters with contact lenses in place using a letter chart. VA was measured in logarithm minimum angle of resolution (logMAR). A logMAR value of 0 equates to 20/20 Snellen visual acuity (normal distance eyesight), with a lower logMAR value indicating better visual acuity.
Day 4
Study Arms (2)
LID220365 (OD) / LID006961 (OS)
OTHERLID220365 contact lens worn in the right eye (OD), with LID006961 contact lens worn in the left eye (OS), as randomized, for four days. A fresh pair of lenses will be worn each day.
LID006961 (OD) / LID220365 (OS)
OTHERLID006961 contact lens worn in the right eye (OD), with LID220365 contact lens worn in the left eye (OS), as randomized, for four days. A fresh pair of lenses will be worn each day.
Interventions
Investigational delefilcon A spherical contact lens made with a modified manufacturing process
Commercially available delefilcon A spherical contact lens
Eligibility Criteria
You may qualify if:
- Successful wearer of spherical soft contact lenses of the same brand in both eyes for a minimum of 5 days per week and 10 hours per day during the past 3 months.
- Manifest cylinder equal to or less than 0.75 diopter (D) in each eye.
- Best corrected visual acuity (BCVA) better than or equal to 0.10 logMAR in each eye.
You may not qualify if:
- Any use of topical ocular medications and artificial tear or rewetting drops that would require instillation during study participation.
- Wearing habitual contact lenses in an extended wear modality (routinely sleeping in lenses for at least 1 night per week) over the last 3 months prior to enrollment.
- Habitual monovision or multifocal contact lens wearers.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Alcon Researchlead
Study Sites (7)
Kindred Optics at Maitland Vision
Maitland, Florida, 32751, United States
Vision Health Institute
Orlando, Florida, 32803, United States
Franklin Park Eye Center PC
Franklin Park, Illinois, 60131, United States
SUNY College of Optometry Clinical Vision Research Center
New York, New York, 10036, United States
Wyomissing Optometric Center
Wyomissing, Pennsylvania, 19610, United States
Optometry Group, PLLC
Memphis, Tennessee, 38111, United States
Clarke Eyecare Center
Wichita Falls, Texas, 76308, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Sr. Clinical Project Lead, Vision Care
- Organization
- Alcon Research, LLC
Study Officials
- STUDY DIRECTOR
Clinical Trial Lead, Vision Care
Alcon Research, LLC
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- OTHER
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 3, 2023
First Posted
February 13, 2023
Study Start
June 2, 2023
Primary Completion
June 27, 2023
Study Completion
June 27, 2023
Last Updated
August 6, 2024
Results First Posted
August 6, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share